Dr Marios Koutsakos
(03) 8344 3384 | marios.koutsakos@unimelb.edu.au
- Position:
- Research Fellow
- Theme(s):
- Immunology, Host Pathogens Interactions
- Discipline(s):
- Discovery Research, Clinical and health systems research
- Unit(s):
- Department of Microbiology and Immunology (DMI)
- Lab Group(s):
- Kent Group
Marios completed his BSc in Biomedical Sciences at Imperial College in London, working with Professor Wendy Barclay on the molecular virology of influenza B viruses. He then obtained a Masters degree in Systems and Synthetic biology, also at Imperial College. Marios subsequently undertook a PhD with Professor Katherine Kedzierska within the Department of Microbiology and Immunology, University of Melbourne, focusing on understanding protective immunity to influenza viruses, especially the understudied but clinically relevant influenza B viruses. Marios is now a Postdoctoral Fellow with the Kent Group, working on dissecting the antigenic evolution and antibody responses to influenza B viruses in order to rationally designing a universal influenza B virus vaccine.
-
Key Achievements
Publications
-
Marios’ work has so far resulted in three first author manuscripts, including highly ranked journals; Nature Immunology and Science Translational Medicine, as well as a patent inventorship on the design of novel universal influenza vaccines. He has received numerous awards, including the QIAGEN PhD Achievement award, as well as the James S Porterfield Prize in international virology by the University of Oxford, the ASI Pharmaxis award, an ASI International Travel Award and was a ASI New Investigator finalist. In 2020 he was a recipient of an NHMRC EL1 fellowship, an ECR grant by the University of Melbourne and a Dyason Fellowship.
Research GroupsLoading ORCID data…-
Kent Group
Stephen’s group studies immunity to HIV, influenza and SARS-CoV-2. They are analysing a variety of vaccine strategies, including nanoparticle-based vaccines. They are studying a series of immune responses to gain better insights into protective immunity to important viral pathogens. They are developing monoclonal antibody therapies for HIV, influenza and SARS-CoV-2 to improve the treatment of these infections. The Kent group works very closely with Dr Amy Chung’s laboratory at the Doherty Institute.
Lab Team
-
Dr Adam WheatleyGroup Leader | Postdoctoral Fellow
-
Group Leader | Post-doctoral Fellow
-
Emily PilkingtonPostdoctoral Fellow
-
Hyon-Xhi TanPostdoctoral Fellow
-
Jacob CoffeyPostdoctoral Fellow
-
Research Fellow
-
Wen Shi LeePostdoctoral Fellow
-
Andrew KellyResearch Assistant
-
Grace GareResearch Assistant
-
Julie NguyenResearch Assistant
-
Robyn EsterbauerResearch Assistant
-
Thakshila AmarasenaResearch Support Officer
-
Jane BattenProject Manager
-
Janavi RambhatlaSenior Project Officer
-
Devaki PilapitiyaPhD Student
-
Ebene HaycroftMasters Student (co-supervisor with Amy Chung)
-
Isaac Barber-AxthelmPhD Student
-
Kirsty FieldPhD Student
-
Mai Ngoc VuPhD Student
-
Samantha DavisPhD Student (co-supervisor with Amy Chung)
-
Thu DoPhD Student
-
Lauren BurmasHonours Student
-
Meghan ConlanHonours Student
-
Professor David O'ConnorHonorary
-
Dr David (Yi) JuHonorary
-
Dr Hillary VandervenHonorary
-
A/Prof Matt ParsonsHonorary
-
Dr Nghia TruongHonorary
-
-